1. Home
  2. ODTX vs BHRB Comparison

ODTX vs BHRB Comparison

Compare ODTX & BHRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$26.77

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Logo Burke & Herbert Financial Services Corp.

BHRB

Burke & Herbert Financial Services Corp.

HOLD

Current Price

$72.84

Market Cap

968.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODTX
BHRB
Founded
N/A
1852
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
968.8M
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
ODTX
BHRB
Price
$26.77
$72.84
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$71.80
AVG Volume (30 Days)
126.1K
104.4K
Earning Date
N/A
04-23-2026
Dividend Yield
N/A
3.46%
EPS Growth
N/A
173.76
EPS
N/A
2.16
Revenue
N/A
N/A
Revenue This Year
N/A
$36.62
Revenue Next Year
N/A
$10.06
P/E Ratio
N/A
$33.13
Revenue Growth
N/A
N/A
52 Week Low
$15.10
$57.42
52 Week High
$26.49
$75.09

Technical Indicators

Market Signals
Indicator
ODTX
BHRB
Relative Strength Index (RSI) 76.70 52.29
Support Level $19.84 $68.38
Resistance Level N/A $73.55
Average True Range (ATR) 1.82 1.36
MACD 0.63 -0.37
Stochastic Oscillator 100.00 47.96

Price Performance

Historical Comparison
ODTX
BHRB

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

About BHRB Burke & Herbert Financial Services Corp.

Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.

Share on Social Networks: